Ann Surg Treat Res.  2019 Jul;97(1):7-14. 10.4174/astr.2019.97.1.7.

Repeat hepatectomy for recurred colorectal liver metastasis: is it justified?

Affiliations
  • 1Center for Liver Cancer, National Cancer Center, Goyang, Korea. sshan@ncc.re.kr
  • 2Center for Colorectal Cancer, National Cancer Center, Goyang, Korea.
  • 3Biometrics Research Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

Abstract

PURPOSE
Liver resection is considered the only curative treatment modality for colorectal liver metastasis. The recurrence rate after hepatectomy is >50%. Two or more hepatectomies are applied to treat recurred metastases. We assessed the efficiency and feasibility of repeat hepatectomy and analyzed the prognostic factors after a repeat hepatectomy.
METHODS
In total, 248 patients were diagnosed with recurred liver metastasis between January 2003 and May 2016. Second and third hepatectomies were performed in 70 and 7 patients, respectively. The other 171 patients did not undergo a repeat hepatectomy. Clinical features were collected from the medical records. We analyzed survival rates of the repeat hepatectomy group and the nonrepeat hepatectomy group. We also investigated factors affecting overall and disease-free survival of patients who received a repeat hepatectomy using univariate and multivariate analyses.
RESULTS
Median overall survival was significantly higher in the repeat hepatectomy group than in the nonrepeat group (83.0 months vs. 25.0 months, P < 0.001). The morbidity and mortality rates of repeat hepatectomy were 9.1% and 0%, respectively. Median overall and disease-free survival of the repeat hepatectomy group were 62.0 and 51.0 months, respectively. The number of recurred tumors was the only significant factor for disease-free survival (P = 0.029). None of the factors affected overall survival.
CONCLUSION
Repeat hepatectomy is necessary, effective, and safe for treating recurred colorectal liver metastasis. Repeat hepatectomy can be considered in patients with fewer than three recurred metastatic tumors.

Keyword

Colorectal neoplasms; Hepatectomy; Feasibility studies; Prognosis; Recurrence

MeSH Terms

Colorectal Neoplasms
Disease-Free Survival
Feasibility Studies
Hepatectomy*
Humans
Liver*
Medical Records
Mortality
Multivariate Analysis
Neoplasm Metastasis*
Prognosis
Recurrence
Survival Rate

Figure

  • Fig. 1 Flow diagram for patient selection. CRLM, colorectal liver metastasis.

  • Fig. 2 Overall survival of the repeat hepatectomy and nonrepeat hepatectomy groups.

  • Fig. 3 Overall (A) and disease-free survival (B) rates of patients who underwent a second hepatectomy.

  • Fig. 4 Overall survival after a third hepatectomy (dotted line) and without a third hepatectomy (solid line).


Cited by  1 articles

Multicenter study of prognostic factors in paraaortic lymph node dissection for metastatic colorectal cancer
Jun Woo Bong, Sanghee Kang, Pyoungjae Park
Ann Surg Treat Res. 2023;105(5):271-280.    doi: 10.4174/astr.2023.105.5.271.


Reference

1. Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am. 2003; 12:165–192. xi
Article
2. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006; 94:982–999.
Article
3. Yamada H, Kondo S, Okushiba S, Morikawa T, Katoh H. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg. 2001; 25:1129–1133.
Article
4. Brandi G, De Lorenzo S, Nannini M, Curti S, Ottone M, Dall'Olio FG, et al. Adjuvant chemotherapy for resected colorectal cancer metastases: literature review and meta-analysis. World J Gastroenterol. 2016; 22:519–533.
Article
5. Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009; 27:872–877.
Article
6. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004; 240:644–657.
7. Saiura A, Yamamoto J, Koga R, Takahashi Y, Takahashi M, Inoue Y, et al. Favorable outcome after repeat resection for colorectal liver metastases. Ann Surg Oncol. 2014; 21:4293–4299.
Article
8. Wicherts DA, de Haas RJ, Salloum C, Andreani P, Pascal G, Sotirov D, et al. Repeat hepatectomy for recurrent colorectal metastases. Br J Surg. 2013; 100:808–818.
Article
9. Jones NB, McNally ME, Malhotra L, Abdel-Misih S, Martin EW, Bloomston M, et al. Repeat hepatectomy for metastatic colorectal cancer is safe but marginally effective. Ann Surg Oncol. 2012; 19:2224–2229.
Article
10. Lopez P, Marzano E, Piardi T, Pessaux P. Repeat hepatectomy for liver metastases from colorectal primary cancer: a review of the literature. J Visc Surg. 2012; 149:e97–e103.
Article
11. Antoniou A, Lovegrove RE, Tilney HS, Heriot AG, John TG, Rees M, et al. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases. Surgery. 2007; 141:9–18.
Article
12. Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN, Conrad C. Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival. Ann Surg. 2016; 263:146–152.
Article
13. de Jong MC, Mayo SC, Pulitano C, Lanella S, Ribero D, Strub J, et al. Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg. 2009; 13:2141–2151.
Article
14. Shaw IM, Rees M, Welsh FK, Bygrave S, John TG. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg. 2006; 93:457–464.
Article
15. Zacharias T, Jaeck D, Oussoultzoglou E, Bachellier P, Weber JC. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg. 2004; 240:858–865.
Article
16. Ishiguro S, Akasu T, Fujimoto Y, Yamamoto J, Sakamoto Y, Sano T, et al. Second hepatectomy for recurrent colorectal liver metastasis: analysis of preoperative prognostic factors. Ann Surg Oncol. 2006; 13:1579–1587.
Article
17. Tanaka K, Shimada H, Ohta M, Togo S, Saitou S, Yamaguchi S, et al. Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer. World J Surg. 2004; 28:482–487.
Article
18. Nishio H, Hamady ZZ, Malik HZ, Fenwick S, Rajendra Prasad K, Toogood GJ, et al. Outcome following repeat liver resection for colorectal liver metastases. Eur J Surg Oncol. 2007; 33:729–734.
Article
19. Ahmad A, Chen SL, Bilchik AJ. Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases. Arch Surg. 2007; 142:526–531.
Article
20. Thelen A, Jonas S, Benckert C, Schumacher G, Lopez-Hanninen E, Rudolph B, et al. Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol. 2007; 33:324–328.
Article
21. Pessaux P, Lermite E, Brehant O, Tuech JJ, Lorimier G, Arnaud JP. Repeat hepatectomy for recurrent colorectal liver metastases. J Surg Oncol. 2006; 93:1–7.
Article
22. Sa Cunha A, Laurent C, Rault A, Couderc P, Rullier E, Saric J. A second liver resection due to recurrent colorectal liver metastases. Arch Surg. 2007; 142:1144–1149.
Article
23. Brachet D, Lermite E, Rouquette A, Lorimier G, Hamy A, Arnaud JP. Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: review of sixty-two cases treated at a single institution. Dis Colon Rectum. 2009; 52:475–483.
24. Sugawara G, Isogai M, Kaneoka Y, Suzuki M, Yamaguchi A. Repeat hepatectomy for recurrent colorectal metastases. Surg Today. 2005; 35:282–289.
Article
25. Battula N, Tsapralis D, Mayer D, Isaac J, Muiesan P, Sutcliffe RP, et al. Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience. HPB (Oxford). 2014; 16:157–163.
Article
26. Fukami Y, Kaneoka Y, Maeda A, Takayama Y, Onoe S. Postoperative complications following aggressive repeat hepatectomy for colorectal liver metastasis have adverse oncological outcomes. Surg Today. 2017; 47:99–107.
Article
27. Kim KH, Yoon YS, Yu CS, Kim TW, Kim HJ, Kim PN, et al. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc. 2011; 81:25–34.
Article
28. Wu YZ, Li B, Wang T, Wang SJ, Zhou YM. Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. World J Gastroenterol. 2011; 17:4143–4148.
29. Lee H, Choi SH, Cho YB, Yun SH, Kim HC, Lee WY, et al. Repeat hepatic resection in patients with colorectal liver metastases. World J Gastroenterol. 2015; 21:2124–2130.
Article
Full Text Links
  • ASTR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr